News &amp; Updates

The serum profile of antibodies and proteins may help identify patients at risk of developing Crohn’s disease within 5 years, a new study reports.

Serum antibodies, proteins may be predictive of Crohn’s disease

Eating near bedtime promotes GERD in pregnant women

A short meal-to-bedtime may cause problems during pregnancy, contributing to an increased risk of gastroesophageal reflux disease (GERD) and reflux-related insomnia, a study has found.

Eating near bedtime promotes GERD in pregnant women

Patients with atopic diseases prone to inflammatory bowel disease

The presence of any atopic disease increases the risk of developing inflammatory bowel disease, which rises progressively as the number of atopic disease increases, a study has found.

Patients with atopic diseases prone to inflammatory bowel disease

Prophylactic clipping of large, proximal lesions cuts postpolypectomy bleeding

Routine prophylactic clipping after polypectomy may not decrease postoperative bleeding, a new meta-analysis has found. However, it may reduce bleeding after the excision of large proximal lesions.

Prophylactic clipping of large, proximal lesions cuts postpolypectomy bleeding

Healthy lifestyle, regular colonoscopy help stave off CRC

06 Aug 2020

Keeping a healthy lifestyle and having regular colonoscopy screenings are effective measures to reduce the risk of developing colorectal cancer (CRC), a new study has shown.

Healthy lifestyle, regular colonoscopy help stave off CRC

06 Aug 2020

DGAT2 a potential therapeutic target for fatty liver?

05 Aug 2020 by

Antisense inhibition of DGAT2* – one of two vital enzymes in triglyceride synthesis – may be a favourable strategy for reversing nonalcoholic fatty liver disease (NAFLD), suggesting that targeting this pathway may mitigate NAFLD progression to its more severe form, nonalcoholic steatohepatitis (NASH), a phase II study has shown.

DGAT2 a potential therapeutic target for fatty liver?

05 Aug 2020

$Faecal transplant a promising therapy for refractory IBS with bloating$

Faecal transplant a promising therapy for refractory IBS with bloating

05 Aug 2020

Patients with treatment-refractory irritable bowel syndrome (IBS) with predominant bloating may fare well with faecal microbiota transplantation (FMT), which has been shown in a study to induce symptom relief. However, the beneficial effects wane over 1 year, and a second FMD appears to re-establish the benefits but only in those who have shown a prior response.

Faecal transplant a promising therapy for refractory IBS with bloating

05 Aug 2020

Tradipitant shows therapeutic potential in patients with gastroparesis

Treatment with tradipitant in patients with idiopathic or diabetic gastroparesis produces meaningful improvements in nausea and vomiting, according to the results of a phase II trial.

Tradipitant shows therapeutic potential in patients with gastroparesis

Patients with inflammatory bowel disease mellow out on cannabis

Use of cannabis or cannabinoids among patients with inflammatory bowel disease (IBD) does little to induce clinical remission or reduce inflammation, although it helps calm patient-reported symptoms and improve quality of life, a study has found.

Patients with inflammatory bowel disease mellow out on cannabis